Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)
Endovascular Correction of Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Evaluation of Influence of These Treatments on the Symptoms of Multiple Sclerosis
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study is to assess the efficacy of endovascular treatment (balloon angioplasty and/or stenting) for the improvement of clinical symptoms in multiple sclerosis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 multiple-sclerosis
Started Mar 2010
Typical duration for phase_1 multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 21, 2010
CompletedFirst Posted
Study publicly available on registry
December 22, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFebruary 10, 2015
February 1, 2015
7 months
December 21, 2010
February 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in clinical symptoms of multiple sclerosis measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance
6 months after the procedure
Study Arms (1)
Balloon angioplasty and/or stenting
EXPERIMENTALBalloon angioplasty and/or stenting of stenosed internal jugular vein and/or azygous vein and/or brachiocephalic vein
Interventions
balloon angioplasty and/or stenting of internal jugular veins and/or azygous vein and/or brachiocephalic veins
Eligibility Criteria
You may qualify if:
- patients with clinically defined multiple sclerosis
You may not qualify if:
- contraindication for endovascular procedure performed in local anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Euromedic Specialist Clinics
Katowice, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marian Simka
Euromedic Specialist Clinics , Katowice , Poland
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
December 21, 2010
First Posted
December 22, 2010
Study Start
March 1, 2010
Primary Completion
October 1, 2010
Study Completion
December 1, 2012
Last Updated
February 10, 2015
Record last verified: 2015-02